Palliare

Executive Summary

Palliare is an Irish medical device company specializing in advanced insufflation and smoke evacuation technologies for minimally invasive gastrointestinal and laparoscopic surgery. Spun out from Crospon (acquired by Medtronic) in 2015, the company aims to enhance procedural safety and efficiency in the operating room. Its flagship product, the EVA15 Insufflator, is designed to provide precise pressure control and effective smoke clearance during laparoscopic and endoscopic procedures, addressing critical needs in modern surgery. As a private, early-stage company, Palliare is focused on regulatory approvals and market entry for the EVA15. With a growing global emphasis on minimally invasive techniques, the company is well-positioned to capture market share. Key upcoming catalysts include regulatory clearances, potential distribution partnerships, and financing to support commercialization. The company's expertise and technology foundation bode well for its trajectory, though execution risks remain.

Upcoming Catalysts (preview)

• Q4 2026CE Mark Approval for EVA15 Insufflator70% success
• Q3 2026Strategic Distribution Partnership in EU60% success
• Q4 2026Series A Funding Round Completion75% success